Silence Therapeutics plc (SLN) stock
SLNNasdaqPharmaceutical PreparationsAlso trades as SLNCF
$19.80+0.00 (0.00%)
Close on Nov 17, 2026Market cap $935.48MP/E –Yield –
Silence Therapeutics cash
Cash and short-term investments held at the end of each period.
Silence Therapeutics's cash was $247.70M at Sep 30, 2026. For fiscal 2025 it was $85.10M, down 42.2% from the year before.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $85.10M | -42.2% |
| FY2024 | Dec 31, 2024 | $147.30M | +114.1% |
| FY2023 | Dec 31, 2023 | $68.79M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $247.70M | +142.4% |
| Q2 FY2026 | Jun 30, 2026 | $72.10M | -36.9% |
| Q1 FY2026 | Mar 31, 2026 | $70.10M | -48.6% |
| Q4 FY2025 | Dec 31, 2025 | $85.10M | -42.2% |
| Q3 FY2025 | Sep 30, 2025 | $102.20M | +48.6% |
| Q2 FY2025 | Jun 30, 2025 | $114.20M | – |
| Q1 FY2025 | Mar 31, 2025 | $136.50M | – |
| Q4 FY2024 | Dec 31, 2024 | $147.30M | – |
| Q4 FY2023 | Dec 31, 2023 | $68.79M | – |
See a number that looks wrong?